Cardiology Grand Rounds - Matt Springer, PhD and Leila Mohammadi, MD, PhD

Matthew Springer, PhD
Dr. Matthew L. Springer received his BA from the University of California, Berkeley in 1985 and his Ph.D. from Stanford University in 1992.  He did postdoctoral research at Stanford and continued his research there as a senior scientist until joining the UCSF faculty in 2003, where he is currently one of three non-clinicians on the faculty of the Division of Cardiology. The close juxtaposition of his basic research background with the clinical cardiologists in the Division has resulted in an active translational research program.   

Dr. Springer's research interests include cell therapy and gene therapy approaches to studying cardiovascular disease, with the goals of exploring potential treatments and understanding underlying mechanisms involved in angiogenesis, vascular function, and treatments for myocardial infarction.  Further interests involve mechanisms underlying vascular reactivity and how they are affected by exposure to tobacco and marijuana smoke.

Leila Mohammadi, MD, PhD
Dr. Mohammadi is a physician-scientist and an Early Career Investigator with over 12 years of experience in clinical vascular studies including pre-doctoral work with much of it focused on studying vascular effects of tobacco and marijuana exposure. She has clinical and research background in cardiac arrhythmias, hypertension, and endothelial dysfunction. Dr. Mohammadi is leading the UCSF CANDIDE study, which investigates the effects of chronic cannabis use on vascular function.

This is a hybrid meeting.